0000899243-21-036134.txt : 20210915 0000899243-21-036134.hdr.sgml : 20210915 20210915174639 ACCESSION NUMBER: 0000899243-21-036134 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210914 FILED AS OF DATE: 20210915 DATE AS OF CHANGE: 20210915 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DAWES KAREN A CENTRAL INDEX KEY: 0001261506 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14656 FILM NUMBER: 211256294 MAIL ADDRESS: STREET 1: 579 BELLEVUE AVE CITY: NEWPORT STATE: RI ZIP: 02840 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REPLIGEN CORP CENTRAL INDEX KEY: 0000730272 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042729386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7814499560 MAIL ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-09-14 0 0000730272 REPLIGEN CORP RGEN 0001261506 DAWES KAREN A C/O REPLIGEN CORPORATION 41 SEYON ST., BLDG 1, STE 100 WALTHAM MA 02453 1 0 0 0 Common Stock 2021-09-14 4 S 0 13 290.02 D 93908 D Common Stock 2021-09-14 4 S 0 25 292.34 D 93883 D Common Stock 2021-09-14 4 S 0 101 294.06 D 93782 D Common Stock 2021-09-14 4 S 0 108 295.02 D 93674 D Common Stock 2021-09-14 4 S 0 27 295.82 D 93647 D Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021. $292.34 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $292.17 to $292.35, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $294.06 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $293.64 to $294.38, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $295.02 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $294.75 to $295.29, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $295.82 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $295.79 to $295.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. /s/ Kimberly Brown (Attorney in Fact) 2021-09-15